CDK4/6 inhibitors as adjuvant treatment for hormone receptor-positive, HER2-negative early breast cancer: a systematic review and meta-analysis

Autor: Agostinetto, E., Vian, L., Caparica, R., Bruzzone, M., Ceppi, M., Lambertini, M., Pondé, N., de Azambuja, E.
Zdroj: In ESMO Open April 2021 6(2)
Databáze: ScienceDirect